Univariable Cox Analyses for OS in Training Cohort*
Parameter | HR† | c-index | P |
---|---|---|---|
Clinical | |||
Age, in y | 1.011 (0.99–1.03) | 0.509 | 0.28 |
Sex | |||
Female | Reference | ||
Male | 1.51 (0.89–2.6) | 0.53 | 0.12 |
Tobacco use | |||
No | Reference | ||
Yes | 2.13 (1.11–4.1) | 0.52 | 0.02 |
Alcohol use | |||
No | Reference | ||
Yes | 1.34 (0.99–4.1) | 0.55 | 0.1 |
PS | |||
0–1 | Reference | ||
2 | 2.65 (1.07–6.5) | 0.52 | 0.03 |
T classification | |||
cT1–cT2 | Reference | ||
cT3–cT4 | 2.01 (1.4–2.9) | 0.61 | 0.003 |
N classification | |||
cN0 | Reference | ||
cN1 | 1.19 (0.69–2.05) | 0.53 | 0.5 |
cN2 | 1.13 (0.75–1.7) | 0.53 | 0.5 |
cN3 | 2.32 (0.83–6.45) | 0.53 | 0.1 |
AJCC staging | |||
I | Reference | ||
II | 2.17 (0.89–5.3) | 0.575 | 0.09 |
III | 3.11 (1.36–7.1) | 0.575 | 0.007 |
IV | 2.59 (1.24–5.4) | 0.575 | 0.01 |
Tumor site | |||
Oral cavity | Reference | ||
Hypopharynx | 1.81 (1.08–3.03) | 0.55 | 0.02 |
Larynx | 1.29 (0.78–2.15) | 0.55 | 0.3 |
Oropharynx | 1.26 (0.75–2.12) | 0.55 | 0.4 |
Metabolic data‡ | |||
Tumor metabolic data | |||
SUVmax | 1.004 (0.988–1.021) | 0.54 | 0.58 |
MTV at 23% of SUVmax | 1.02 (1.01–1.03) | 0.64 | <0.001 |
MTV at SUV of 2.5 | 1.01 (1.001–1.014) | 0.61 | 0.038 |
TLG at 21% of SUVmax | 1.001 (1.00–1.01) | 0.61 | 0.04 |
TLG at SUV of 1.5 | 1.001 (1.000–1.002) | 0.61 | 0.038 |
Node metabolic data | |||
MTV at 21% of SUVmax | 1.007 (1.001–1.013) | 0.566 | 0.014 |
MTV at SUV of 3.0 | 1.010 (1.000–1.019) | 0.563 | 0.014 |
TLG at 21% of SUVmax | 1.001 (1.000–1.002) | 0.564 | 0.02 |
TLG at SUV of 3.0 | 1.001 (1.000–1.002) | 0.551 | 0.036 |
Maximal tumor–node distance | 1.04 (0.99–1.1) | 0.57 | 0.08 |
dst_TBarycenterN | 1.08 (1.01–1.16) | 0.58 | 0.02 |